RxDoctor Payments Data

Xinnan Wang

Optometrist · Fort Worth, TXNPI 1740776657

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.3% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Coopervision Inc. at 38.1% of the total. Reporting peaked in 2019 at $194 and has fallen 93.0% since, to $14 in 2023. That places this record below the midpoint for optometrist clinicians in TX, where the typical reported total is $910.

$366in general payments, 2019–2025

Across 7 payments — averaging $52.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coopervision Inc.$140
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$97
  • Johnson & Johnson Vision Care, Inc.$82
  • Alcon$30
  • Carl Zeiss Meditec, Inc.$17
$125,000in research payments, 2019–2025

Across 1 payment — averaging $125,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$125K

What the payments were for

  • Food & beverage$34995%
  • Gifts$175%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$366 in reported general payments places this provider in the 25th percentile of 4,315 optometrist providers in Texas.

See all optometrist providers in Texas

Medicare billing

Part B allowed, 2024
$4,023
Medicare patients
33
Services billed
35

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other optometrist in Fort Worth

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →